This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.

Novartis Investigative Site, Taipei

Novartis Investigative Site, Brussels

Novartis Investigative Site, 's-Hertogenbosch

SUNY - Upstate Medical University, Syracuse

Novartis Investigative Site, Jaén

Novartis Investigative Site, Madrid

Novartis Investigative Site, Oviedo

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Giessen

Novartis Investigative Site, Cologne

Novartis Investigative Site, Sakarya

Novartis Investigative Site, Thessaloniki

University of Kansas Medical Center Neurology Dept., Kansas City

Novartis Investigative Site, Bron

Novartis Investigative Site, Paris

Methodist Hospital / Methodist Cancer Center, Houston

UCLA Oncology Hematology, La Jolla

Novartis Investigative Site, Bad Berka

Novartis Investigative Site, Taipei

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Saint Petersburg

Novartis Investigative Site, Omsk

Novartis Investigative Site, Montreal

Novartis Investigative Site, Halle

Novartis Investigative Site, Kashiwa

Novartis Investigative Site, Breda

Novartis Investigative Site, Maastricht

Novartis Investigative Site, Izmir

Novartis Investigative Site, Sihhiye / Ankara